A Study of (Interleukin-12) IL-12 in Patients With Acute Myelogenous Leukemia (AML)
Clinical trial NCT02483312 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT02483312
- Sponsor
- University Health Network, Toronto
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2015-09-01
- Primary completion
- 2026-08-01
- Enrollment
- 9
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.